XCancer Omaha — Omaha, Nebraska

XCancer Omaha is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

XCancer Omaha has participated in 7 clinical trials with 6 currently active.

Therapeutic areas: Metastatic Castration-resistant Prostate Cancer, Cancer, Advanced Metastatic Castration-resistant Prostate Cancer.

Sponsors: Bayer, Oncternal Therapeutics, Inc, Telix Pharmaceuticals (Innovations) Pty Limited.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for XCancer Omaha?

XCancer Omaha has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has XCancer Omaha conducted?

XCancer Omaha has 7 clinical trials on record, with 6 currently active. Their work covers Metastatic Castration-resistant Prostate Cancer, Cancer, Advanced Metastatic Castration-resistant Prostate Cancer.

Is XCancer Omaha accredited by Crixeo Health?

XCancer Omaha has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about XCancer Omaha?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.